Bioceres Crop Solutions Corp. (NASDAQ:BIOX) to Post FY2025 Earnings of $1.24 Per Share, Brookline Capital Management Forecasts

Bioceres Crop Solutions Corp. (NASDAQ:BIOXFree Report) – Equities researchers at Brookline Capital Management decreased their FY2025 EPS estimates for Bioceres Crop Solutions in a report released on Thursday, February 8th. Brookline Capital Management analyst K. Dolliver now anticipates that the company will post earnings of $1.24 per share for the year, down from their prior estimate of $1.38. The consensus estimate for Bioceres Crop Solutions’ current full-year earnings is $0.67 per share. Brookline Capital Management also issued estimates for Bioceres Crop Solutions’ FY2026 earnings at $1.74 EPS, FY2027 earnings at $2.05 EPS and FY2028 earnings at $2.32 EPS.

Bioceres Crop Solutions (NASDAQ:BIOXGet Free Report) last issued its earnings results on Thursday, February 8th. The company reported $0.09 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.07 by $0.02. Bioceres Crop Solutions had a net margin of 4.36% and a return on equity of 5.97%. The firm had revenue of $140.30 million during the quarter, compared to analyst estimates of $108.97 million. During the same period in the previous year, the firm earned ($0.14) earnings per share.

Separately, Roth Mkm upped their price objective on shares of Bioceres Crop Solutions from $20.00 to $21.00 and gave the stock a “buy” rating in a research note on Friday.

Check Out Our Latest Analysis on Bioceres Crop Solutions

Bioceres Crop Solutions Stock Up 2.1 %

NASDAQ:BIOX opened at $13.86 on Monday. Bioceres Crop Solutions has a 1-year low of $9.76 and a 1-year high of $14.20. The company has a 50-day moving average of $13.38 and a 200 day moving average of $12.06. The firm has a market cap of $870.41 million, a PE ratio of 43.31 and a beta of 0.54. The company has a debt-to-equity ratio of 0.38, a current ratio of 1.27 and a quick ratio of 0.82.

Hedge Funds Weigh In On Bioceres Crop Solutions

Hedge funds and other institutional investors have recently modified their holdings of the stock. Advisor Group Holdings Inc. raised its position in Bioceres Crop Solutions by 66.9% during the 4th quarter. Advisor Group Holdings Inc. now owns 2,242 shares of the company’s stock worth $27,000 after buying an additional 899 shares during the last quarter. Cape Investment Advisory Inc. purchased a new position in Bioceres Crop Solutions during the 4th quarter worth approximately $33,000. Lazard Asset Management LLC purchased a new position in Bioceres Crop Solutions during the 4th quarter worth approximately $49,000. Goldman Sachs Group Inc. purchased a new position in Bioceres Crop Solutions during the 2nd quarter worth approximately $176,000. Finally, Sei Investments Co. acquired a new stake in shares of Bioceres Crop Solutions during the 2nd quarter worth approximately $221,000. 13.35% of the stock is owned by hedge funds and other institutional investors.

Bioceres Crop Solutions Company Profile

(Get Free Report)

Bioceres Crop Solutions Corp., together with its subsidiaries, provides crop productivity solutions. It operates through Seed and Integrated Products, Crop Protection, and Crop Nutrition segments. The Seed and Integrated Products segment provides seed traits, germplasms, and seed treatment packs for healthier, and higher yielding crops.

Further Reading

Receive News & Ratings for Bioceres Crop Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bioceres Crop Solutions and related companies with MarketBeat.com's FREE daily email newsletter.